Inhaler update

A problem whereby some pharmacies may be unable to process claims for supply of an inhaler is now subject to an interim solution The 1 July 2023 PBS Schedule included approved changes to the listings of the form “budesonide 400 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 12 microgram/actuation powder for inhalation” for the purpose of